John Franklin Fowler - 14 Dec 2021 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role: CEO, Director
Signature: /s/ Marc Belsky, Attorney-in-Fact
Issuer symbol: KZR
Transactions as of: 14 Dec 2021
Net transactions value: +$6,930
Form type: 4
Filing time: 15 Dec 2021, 17:05:14 UTC
Next filing: 07 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KZR	Common Stock	Options Exercise	$6,930	+7,700	+2.1%	$0.9000	366,904	14 Dec 2021	Direct
holding	KZR	Common Stock						3,750	14 Dec 2021	By Trust
holding	KZR	Common Stock						38,461	14 Dec 2021	By Montebello Holdings LLC	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KZR	Employee Stock Option (Right to Buy)	Options Exercise	$0	-7,700	-8.5%	$0.000000	82,721	14 Dec 2021	Common Stock	7,700	$0.9000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person is a member of Montebello Holdings LLC. The reporting person disclaims Section 16 beneficial ownership of the securities held by Montebello Holdings LLC, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
F2	Fully vested.